5/14/2026

speaker
Unidentified
Unknown

Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. ¶¶ Thank you. Thank you. Thank you.

speaker
Operator
Conference Operator

Good morning and welcome to KP Tissue's first quarter 2026 results conference call. Today's call is being recorded for replay. All participants are currently in listen-only mode. Following the presentation, we will conduct a question and answer session. Instructions will be provided at the time for you to queue up for questions. If at any time you have difficulties hearing the conference, please press star followed by zero for operator assistance. I will now turn the call over to Doris Grubeck, Director of Investor Relations. You may begin your conference.

speaker
Doris Grubeck
Director of Investor Relations

Thank you, operator. Good morning, everyone, and thank you for joining us to review Kruger Products' first quarter 2026 financial results. With me this morning is Dino Bianco, the CEO of KP Tissue and Kruger Products, and Michael Keyes, the CFO of KP Tissue and Kruger Products. Today's discussion will include certain forward-looking statements. Actual results could differ materially from these forward-looking statements due to known and unknown risks and uncertainties. a list of risk factors can be found in our public filing. In addition, today's discussion will include certain non-GAAP financial measures. The reconciliation of these non-GAAP financial measures to the most comparable GAAP measure can be found in our MD&A. The press release reporting our Q1 2026 results was published this morning and will be available on our website at kptissuant.com. The financial statements in MD&A will also be posted on our website and on CDAR+. The investor presentation to accompany today's discussion can be found in the investor relations section of our website. I will now turn the call over to our CEO, Dino Bianco. Dino?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Thank you, Doris. Good morning, everyone, and thank you for joining us for our first quarter earnings call for fiscal 2026. Despite a volatile economic environment, we generated Q1 2026 adjusted EBITDA of $86.9 million and a margin of 16%. which is driven mainly by lower year-over-year pulp prices and warehousing costs. Our top line declined slightly by 0.3% due to unfavorable foreign exchange impact and a high year-over-year comparison against the prior year quarter that delivered double-digit revenue growth. Overall, we are pleased with our financial performance in the opening quarter. Looking ahead to the remainder of 2026, market demand for our leading tissue products remains healthy Production rates across our paper machines and converting lines are exceeding targets at all sites, and this is supporting our continued momentum on the revenue side. In early April, we also began ramping up the state-of-the-art converting line at our Memphis facility, which is expected to add capacity to our growing U.S. network. We will also actively focus on margin delivery in light of escalating input costs, including higher fuel and freight expenses, by continuing to assess our basket of product costs to determine any potential need for pricing. Now let's take a closer look at our quarterly numbers on slide six. As mentioned, we delivered adjusted EBITDA of nearly $87 million in the first quarter of 2026, up 14.6% year-over-year on relatively stable revenue of $544.6 million. Revenue in Canada improved 0.8% in the first quarter, while sales in the United States declined 1.5%. It should be noted that we were lapping a high comparable in the United States with sales growth of more than 21% in the first quarter of 2025. Let's look at pulp prices. NBSK average prices in Canadian dollars decreased sequentially in year-over-year in the first quarter of 2026, while BEK prices were up during the same comparable periods. This variance in pulp prices can be attributed to an overcapacity of NBSK in the market. Industry analysts expect both NBSK and BEK prices to trend upwards in 2026, but BEK should accelerate at a faster pace and higher level. Let's move on to our operations on slide eight. As previously mentioned, our manufacturing assets exceeded expectations across all our network sites in the first quarter of 2026. In addition, we are pleased to report that we maintained our strong safety record in Q1. At Memphis, our new state-of-the-art converting line, which launched as scheduled early in the second quarter, will support our renewed focus on premium products, specifically in the bathroom tissue and paper towel categories. With Memphis meeting production targets, we are pleased that the turnaround is progressing well, and I want to thank the entire Memphis team for making this happen. Regarding our proposed TAD facility in the Western United States. We are finalizing incentives and permitting and financing and with the preferred location and expect to make an official announcement before the end of the first half of 2026. The project involves construction of new state of the art tissue plant featuring the most modern through air drying paper machine and related converting lines. The facility will allow the company to better service its fast growing US business with ultra premium tissue products. The new TAD machine will have an annual production capacity of approximately 75,000 metric tons, with startup expected in late 2028. Let's turn to brand support. We continue developing strong on-air equity campaigns for our cashmere sponge towels and Scotties brand, along with our Kruger Big Assist program for hockey families, including our role as official partner of the CBC Olympic broadcast. In addition, we activated our annual Scotties Tournament of Hearts campaign, Cougar Products has been a proud sponsor of the Canadian Women's Curling Championship for 45 years. Congratulations to the Innerson Rink for winning the 2026 event in Mississauga. Also during the first quarter, we launched our Find the Cup to Win promotion for the Stanley Cup Playoffs. Further, we introduced a collection of nature-inspired plastic-free Bonterra facial tissue boxes created by Canadian interior designer and TV personality Sarah Richardson. This collaboration is a natural fit for a sustainable Bonterra brand, blending eco-conscious products with stylish home decor. Finally, we continued to build trial and awareness behind our new Scotty's Ultra Soft brand in the first quarter. Let's turn to slide 10. The data presented is taken from Nielsen and shows Kruger Products' branded market share performance in Canada over a 52-week period ending March 21, 2026. The numbers reflect a relatively stable share in the highly competitive bathroom tissue category, and in paper towel, our share grew slightly, but we continue to see momentum in this segment, and we intend to continue to build on our number two position. In facial tissue, we raised our leadership position to almost a 47th share of the Canadian market, supported by strong investments in our Scotty's brand and innovations. Let's look at our away from home segment. Q1 2026 revenue volume profitability grew year over year, but declined sequentially due to seasonality. It should be noted that away from home revenue growth in the first quarter was mainly driven by the U.S. market, which is seeing stronger performance relative to Canada. Profitability improved from the same period last year, driven by cost savings from paper insourcing. Our cashmere, Scotties, and Titan wiper brands continue to deliver growth in the first quarter. I will now turn the call over to Michael.

speaker
Michael Keyes
CFO of KP Tissue and Kruger Products

Thank you, Dino, and good morning everyone. Please turn to slide 12 for a summary of our financial performance for the first quarter of 2026. As Dino mentioned, we generated an adjusted EBITDA of $86.9 million on sales of $544.6 million in the quarter, representing a strong year-over-year adjusted EBITDA growth of 14.6%. Then income total $19.8 million in Q1 2026 compared to $15.4 million in the first quarter of 2025. The year-over-year increases due to higher adjusted EBITDA of $11.1 million, lower depreciation expense of $1.5 million, and reduced interest and other finance costs of $1.3 million. These items were partially offset by unfavorable FX difference of $5.6 million as well as higher income tax expense of $4.2 million. In our quarterly segmented view on page 13, revenue from our consumer business decreased slightly by 0.8% year-over-year to $461.7 million. The slight decline was primarily due to unfavorable FX impact from U.S. dollar sales and higher U.S. sales volume was essentially offset by the decrease in Canada. In our away-from-home segment, Revenue improved 2.5% year-over-year to $82.9 million, due primarily to higher U.S. volumes. The consumer-adjusted EBITDA in the first quarter totaled $83.9 million, compared to $76.1 million in Q1 2025, with a margin of 18.2%, representing an improvement of two points over the same period last year. On a sequential basis, consumer-adjusted EBITDA increased by $5.8 million from Q4 2025. For our away-from-home business, adjusted EBITDA amounted to $6.3 million compared to $2.8 million in Q1 2025. The margin more than doubled year-over-year to 7.6%, partially driven by the expected benefits of insourcing our paper supply. And sequentially, AFH adjusted EBITDA decreased $3.4 million from Q4 2025, driven by some of the seasonality we see in Q1 volume for AFH. Moving on to slide 14, we show our consolidated revenue for Q1 2026, which reached $544.6 million, down slightly by 0.3% year-over-year. The decrease was primarily due to unfavorable FX impact, lower selling prices in the U.S., and a slightly lower volume in Canada. These items were partially offset by slightly higher AFH and consumer volume in the U.S., and a small favorability in our Canadian pricing. On a geographic basis, revenue in Canada grew 2.4 million, or 0.8%, year-over-year, while U.S. revenue decreased 3.9 million, or 1.5%. Now on slide 15, we provide the details of our year-over-year profitability. The adjusted EBITDA increased 11.1 million to 86.9 million, resulting in a margin of 16%, compared to 13.9% for the same period last year. The year-over-year increase was driven by the lower pulp prices, reduced warehousing costs, partially offset by some of the higher manufacturing overhead costs. Now, if we turn to slide 16, where we compare Q1 revenue to Q4 2025, revenue decreased $15.5 million sequentially, or 2.8%, primarily due to lower Canadian sales volume and unfavorable FX impact, which were partially offset by higher selling prices. Geographically, revenue in Canada declined by 17.5 million or 5.7%, while U.S. revenue increased by 2 million or 0.8%. On slide 17, adjusted EBITDA improved sequentially by 2.7 million or 3.2% to 86.9 million, mainly due to lower manufacturing overhead costs, reduced SG&E expenses, and slightly higher selling prices. These factors were partially offset by lower Canadian volume, elevated freight costs and warehousing expenses, higher pulp prices, and an unfavorable FX impact. The adjusted EBITDA margin reached 16.0% in the first quarter compared to 15.0% in Q4 2025. Now turning to our balance sheet and financial position on slide 18, our cash position continued to improve, reaching $205.9 million at the end of the first quarter, up from $196.1 million at the end of Q4 2025. The increase was primarily due to the higher adjusted EBITDA. Long-term debt at quarter end stood at $1.5 billion, a decrease of $16.1 million sequentially, reducing net debt by $14.4 million. Our leverage ratio also declined to 2.9 times compared to 3.1 times in Q4 2025, further demonstrating our commitment to strengthening our balance sheet. Now to conclude my section, we will review capital expenses on slide 19. Our CapEx for Q1 2026 totaled $16 million. And for 2026, we expect to be in the range of $100 to $120 million, which will include some spending related to strategic projects that we've previously shared. Thank you for joining us this morning, and I'll now turn the call back to Dino.

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Thank you, Michael. Let's turn to my closing comments. Summarized, very pleased with our profitability in the first quarter, and we intend to actively focus on margin delivery given escalating and uncertain input costs. We will continue to monitor our total basket of product costs to assess any need for potential pricing. Secondly, we're ramping up our new converting line in Memphis, which will add capacity to our U.S. network in addition to the stronger performance. I think we have a great opportunity to increase sales driven by that capacity. We will continue investing in our brands, drive long-term share growth. We expect our away-from-home segment to continue to deliver against the profitable growth model. As mentioned, we are finalizing the details for the new TAD tissue plant in the western United States, which is expected to start up in late 2028. And we continue to develop our organizational capability to strengthen our adaptability and resilience. Finally, our adjusted EBITDA outlook for the second quarter of 2026 is expected to be in the range of our first quarter 2026 results. We will now be happy to take your questions.

speaker
Operator
Conference Operator

Ladies and gentlemen, we will now begin the question and answer session. If you have a question, please press star followed by the number one on your touch-tone phone. You will hear a prompt that your hand has been raised. If you would like to withdraw from the polling process, please press star then the number two. If you are using a speakerphone, please make sure to lift your handset before pressing any case. Your first question comes from the line of Hamir Patel from CIBC Capital Markets. Your line is now open.

speaker
Hamir Patel
Analyst, CIBC Capital Markets

Hi, good morning. Dito, could you... Walk us through the cost mitigation initiatives that you've put in place since the war in the Middle East started, and with respect to pricing, are there any planned increases in the market?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Well, this is all recent news, obviously, so we're watching it very closely. It didn't have a significant impact on Q1, but if prices stay where they are, they will likely have a greater impact in towards the second half of the year. I would say from a cost mitigation point of view, it's been pretty well business as usual. We haven't made any dramatic changes. We have rejected some cost increases from our suppliers that we felt were a little aggressive or premature. So we have taken that stand. The other thing, Amir, when we look at pricing our business, we look at our basket of goods. So that would include pulp, which is the biggest driver, both MBEK and BEK. and then other key factors like freight and packaging and labor and so forth. So we'll manage the whole basket. Paul's been a little favorable. Some of the other oil and oil-based costs are starting to increase, so we're watching the dynamics of what's going on. And listen, at the end of the day, we're going to deliver our margin, and we'll do it through cost initiatives as well as pricing if we have to.

speaker
Hamir Patel
Analyst, CIBC Capital Markets

Fair enough, but sorry, just to confirm, you don't have any new price increases that are currently in the market?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Nothing has been announced in the market currently, no.

speaker
Hamir Patel
Analyst, CIBC Capital Markets

Okay. And I noticed your parent company, Kruger, increasingly announced a $333 million project to enter the white non-women's market. Are there going to be any sales synergies across the enterprises once this new venture comes online?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, clearly we're looking at it. WIPES has always been an adjacency opportunity for us. I think with this investment it gives us an opportunity to decide where we want to play, if and where we want to play in that segment. So I know my team is actively involved in looking at future plans and what opportunities we may have given what I think is a strong investment and has been a strong point of difference in the marketplace.

speaker
Hamir Patel
Analyst, CIBC Capital Markets

Great. And just lastly, I noticed the slide deck referenced late 2028. Has there been any sort of change in timing there? I think previously you just sort of pointed to 2028, but I wasn't sure if things have been pushed out a quarter or two.

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, I think it's always been late 2028 in our mind. I would say the process is probably taking a little longer, just given a lot of uncertainty in the world and market and working very closely with our lead location and just it's pretty dynamic. And I think we're moving in a very positive direction. And as I said, I hope we have an announcement out before the end of Q2. But still progressing on plan, still progressing with the 2028 startup. We just wanted to create a little more certainty that it's more later in 2028 than earlier.

speaker
Hamir Patel
Analyst, CIBC Capital Markets

Great. Thanks. That's all I had. I'll turn it over.

speaker
Operator
Conference Operator

Your next question comes from the line of Ahmed Abdulla from National Bank of Canada. Your line is now open.

speaker
Ahmed Abdulla
Analyst, National Bank of Canada

Good morning, and thanks for taking my question. Your adjusted even-dom margin improvement was pretty substantial. How much of that expansion came from the costs going down versus the Memphis productivity gain?

speaker
Michael Keyes
CFO of KP Tissue and Kruger Products

Ahmed, it's Michael here. Overall, the improvements over a complete operation network definitely had a positive impact on our cost structure and that enabled us to obviously offset the slight increases that we saw in pulp or even fuel towards the end of the quarter. Overall, we still ended the quarter in a positive position overall in their cost structure. We do expect this performance to be as strong in the coming quarters as well. Obviously, if the fuel and other commodities continue to increase at the rate they've been increasing over the last few weeks, decisions around our commodity contracts that we have our customers and so on will trigger pricing discussions, at least with the ones that are on contracts. to be able to maintain the margins that you've seen in Q3, Q4, and Q1. We believe that our margin will stay fairly strong throughout events like this compared to when it was in 2022, based on how we're approaching commodities today versus the past.

speaker
Ahmed Abdulla
Analyst, National Bank of Canada

Okay, thanks. But does that mean that your Q2 outlook kind of accounts for some pricing that's already embedded in that?

speaker
Michael Keyes
CFO of KP Tissue and Kruger Products

No, there's been no announcement for pricing, as Dino mentioned already. So even when we do announcements, these can take up to two months to take effect. So based on where we're at today, there's currently no announcement made in the market for pricing.

speaker
Ahmed Abdulla
Analyst, National Bank of Canada

Understood. And then just touching on volumes, your Canada consumer volumes were a bit lower while pricing was better. Are you seeing some category softness there, or is there some deliberate pricing moves happening there?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, that's a good question. It's Dino here. We are seeing category softness. Nielsen reported data for Q1 which show the category down 1% on units. I think that's driven by a few things. Lower population growth, I think that's temporary, but there's an adjustment going on in population. I think there is some less discretionary in spending on paper towel, which is more of a discretionary product because we've seen that segment down a little more than the average. I think consumers are pantry deloading or moving to just-in-time buying for tissue, which is probably having some impact there and Maybe there's some non-measured channels where consumers are shopping, like ethnic or health, that we're not picking up. But there has been some softness in the market in Q1. Actually, both in Canada and the United States, we're much closer to the Canadian market because of our brands. So it's been down about 1%.

speaker
Ahmed Abdulla
Analyst, National Bank of Canada

Okay, thanks for the call there. I'll pass the line.

speaker
Operator
Conference Operator

Your next question comes from the line of Sean Stewart from TD Collin. Your line is now open.

speaker
Sean Stewart
Analyst, TD Collin

Thanks. Good morning, everyone. Dino, I know this won't have a bearing on your U.S. expansion plans, but GP has announced more tissue capacity growth on the TAD side in 2028 as well. And I guess the question is more around sector operating rates, the industry's ability to absorb more supply? How do you see operating rates for the broader industry trending and an ability to bring your project in as others are also adding supply?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, great question, Sean. You know, before we announced our project, we did extensive long-term scenario planning on demand forecasts and capacity forecasts using industry information, including some conservative numbers around population growth. It continued to show the need for all the announced machines and potentially a few more. And obviously, GP coming in now kind of validates that the market will be tight. As we look out to 2033, the market will continue to be tight. We still believe that utilization rates will be in the mid-90s, which is probably a stable place to be. There might be some bumpiness, if you will, as individual sites start up over time. As you know, there's quite a few sites starting up in 27, 28, 29. We don't see a change in the long-term dynamics. We feel comfortable with the, first of all, location that we're going to have, the ability to service a lot of our existing customers that are growing. and be able to service existing customers versus having to go after new customers. So we feel comfortable in the long-term dynamics of setting up that site, and we'll be ready with some contingency planning if there's some short-term bumpiness, if you will, as the sites come up.

speaker
Sean Stewart
Analyst, TD Collin

Okay, thanks for that. And with respect to your Western US project, I guess what's left to finish off before you officially move ahead with it and we can get a better sense of the project economics and funding plan?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, I would say there's two left. One is in a broad bucket would be just finalizing the incentive investment scenarios from the city, counties, and states. So we're on the verge of getting those all contracted up. I think we have agreements in principle now on all of them. So now it's a matter of getting pen to paper and understanding how that will play out and the obligations of both parties. So working aggressively with that side of it. The second side, which is probably will be the last piece, is just the final approval on financing. We've been working with our lead banks around the project and getting their uh interest in it uh but obviously that won't be signed up until everything comes together but we don't see any issues with that so those are really the two last pieces okay uh that's all i have thanks very much guys wait this and gentlemen as a reminder if you would like to ask a question please press tar followed by the number one on your touchstone phone

speaker
Operator
Conference Operator

If you are using a speakerphone, please make sure to lift your handset before you press any keys. Your next question comes from the line of Frederick Tremley from Desjardins. Please go ahead.

speaker
Frederick Tremley
Analyst, Desjardins

Thank you. Good morning. Looking at the revenue drivers in the quarter, we see favorable pricing in Consumer Canada, but lower volumes, and then the opposite in the U.S. with unfavorable pricing and higher volumes. Does that mean that we've reached a key pricing level in terms of consumer price elasticity? And do you expect resistance if you had to pass through additional costs in future quarters?

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, I would say that our pricing has been stable. I think what you're seeing is a bit more of a mixed aspect there that's going on in Canada specifically. We have not made any pricing changes up or down since the last update. Yeah, nobody wants the price. I mean, we understand how constrained the consumer is and the mindset of consumers. It's a tough market out there. So we would only do it if that was our last resort. So that's why we're being careful to watch it and making sure we're evaluating a full basket of goods. You know, it's a volatile market out there. The oil prices, you could argue, I mean, you can't argue it. It's a fact that it's event-based. If that event goes away, then we could see that coming back down to maybe more normal levels. Pulp has been certainly pushing a little more upwards with BEK moving quicker, so we'll see how fast and how high that starts to go. At the end of the day, all I can say is we're going to certainly target our margin delivery. We're going to do it through some cost incentives, and if we have to, we're going to price the business. That will only be determined once we understand the cost of the environment around us. On the U.S. side, the U.S. side, a little different. In Canada, we price the general market. In the U.S., we've got contracts, and some of those expire at different points in time, and they're based on the same basket of goods, but they don't all happen at the same time. So you'll see some ebb and flow. Decreases and increases at any point in time, depending on when those contracts come due. And that's probably what you're seeing a little bit of on the US side.

speaker
Frederick Tremley
Analyst, Desjardins

That's very helpful. Thanks for that. And just moving to the Away From Home channel, just your general thoughts and outlook, given the uncertain macro environment. If I'm not mistaken, I think for the quarter you mentioned a bit more strength in the U.S. compared to Canada and AFH. I'm wondering if you could provide a bit more color on the factors behind that.

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Yeah, I just think, you know, at least in the first quarter, maybe it has changed in the month of April and May, there was more strength in the U.S. marketplace just economically. I think there's more, you know, higher consumer confidence, just more better – the indicators around GDP performance and so forth. So I think that's driving it. And then specifically for us, we're a smaller player in the U.S., so it's, you know, growth with our customers will show more of an impact on our total business than anything in Canada because of the fact that, you know, we're coming off a small base.

speaker
Frederick Tremley
Analyst, Desjardins

Great. That's all I have. Thank you.

speaker
Operator
Conference Operator

Thank you. There are no further questions at this time. I would like to turn the call back to Dino Bianco for closing comments. Sir, please go ahead.

speaker
Dino Bianco
CEO of KP Tissue and Kruger Products

Great. Thank you. Thank you. Thank you all for joining us on the call today. We look forward to speaking with you again following the release of our second quarter results for 2026. I do want to remind you that on June 15th at 11 a.m. Eastern Time, we will be hosting our annual meeting of shareholders at the TMX Market Center in Toronto. Your vote and participation at the annual meeting are important to us. Thank you and have a great day.

speaker
Operator
Conference Operator

Ladies and gentlemen, this concludes today's conference call. Thank you very much for your participation. You may now disconnect.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-